<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>TableÂ 3</label>
 <caption>
  <p>Allergic rhino-conjunctivitis-specific recommendations from ARIA/EAACI (from: Bousquet et al. 2020) [
   <xref ref-type="bibr" rid="CR37">37</xref>]
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td align="left">With the current knowledge, in patients with COVID-19 infection, intra-nasal corticosteroid (including spray) can be continued in allergic rhinitis at the recommended dose</td>
   </tr>
   <tr>
    <td align="left">Stopping local intra-nasal corticosteroid is not advised. Suppression of the immune system has not been proven and more sneezing after stopping means more spreading of the Coronavirus</td>
   </tr>
   <tr>
    <td align="left">These recommendations are conditional since there is a paucity of data and they should be revised regularly with new knowledge</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
